OAM
BIIB icon

Optimal Asset Management’s Biogen BIIB Stock Holding History

Optimal Asset Management’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		$2.3M Buy
8,135
+22
+0.3% +$7.21K 0.29% 129
2021
Q2 		$2.81M Hold
8,113
– – 0.33% 113
2021
Q1 		$2.27M Buy
8,113
+3,100
+62% +$836K 0.29% 129
2020
Q4 		$1.23M Hold
5,013
– – 0.17% 200
2020
Q3 		$1.42M Buy
5,013
+1,674
+50% +$467K 0.21% 164
2020
Q2 		$893K Sell
3,339
-2,687
-45% -$808K 0.14% 231
2020
Q1 		$1.91K Buy
6,026
+3,620
+150% +$1.1M 0.18% 194
2019
Q4 		$714K Buy
+2,406
New +$668K 0.11% 277

Other funds holding BIIB

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Optimal Asset Management's BIIB Position: Q3 2021 in Review

Optimal Asset Management increased its Biogen (BIIB) stake by 0.27% in Q3 2021, buying an estimated $7.21K and bringing the position to 8,135 shares worth $2.3M. The position accounts for 0.29% of the portfolio, ranked #129.

Optimal Asset Management first reported a position in BIIB in Q4 2019 and has held it in 8 quarters since. The position peaked at $2.81M in Q2 2021. 1,039 funds tracked by Wall St. Rank hold BIIB as of Q3 2021.

  • Optimal Asset Management held 8,135 shares of Biogen worth $2.3M as of Q3 2021.
  • Optimal Asset Management bought 22 Biogen shares in Q3 2021, an estimated $7.21K.
  • Biogen made up 0.29% of Optimal Asset Management's portfolio in Q3 2021, its #129 holding.
  • Optimal Asset Management first reported a position in Biogen in Q4 2019 and has held it in 8 quarters since.
  • Optimal Asset Management's Biogen position peaked at $2.81M in Q2 2021.
  • 1,039 funds tracked by Wall St. Rank held Biogen as of Q3 2021.

Based on Optimal Asset Management's 13F filing for Q3 2021, filed 15 Nov 2021.